13-112690429-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015205.3(ATP11A):c.13C>T(p.Leu5Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,346,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015205.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP11A | ENST00000375645.8 | c.13C>T | p.Leu5Phe | missense_variant | 1/30 | 5 | NM_015205.3 | ENSP00000364796.3 | ||
ATP11A | ENST00000375630.6 | c.13C>T | p.Leu5Phe | missense_variant | 1/29 | 5 | ENSP00000364781.2 | |||
ATP11A | ENST00000487903.5 | c.13C>T | p.Leu5Phe | missense_variant | 1/30 | 5 | ENSP00000420387.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151770Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000135 AC: 1AN: 74254Hom.: 0 AF XY: 0.0000233 AC XY: 1AN XY: 42962
GnomAD4 exome AF: 0.00000753 AC: 9AN: 1194490Hom.: 0 Cov.: 30 AF XY: 0.00000860 AC XY: 5AN XY: 581614
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151770Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74128
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2024 | The c.13C>T (p.L5F) alteration is located in exon 1 (coding exon 1) of the ATP11A gene. This alteration results from a C to T substitution at nucleotide position 13, causing the leucine (L) at amino acid position 5 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at